WRB · Q4 2025 Earnings
NeutralW. R. Berkley Corporation
Reported January 26, 2026
30-second summary
Berkley closed 2025 with an 89.4% combined ratio — the cleanest underwriting print of the year — a 21.4% ROE, and FY operating EPS of $4.33, but headline revenue grew only +1.5% YoY to $3.72B as Insurance NPW decelerated sharply to +1.7% and Reinsurance & Monoline Excess NPW grew +5.4%. The pivot worth flagging: management is signaling "meaningful investments" in tech and AI through 2026–2027 that will pressure the expense ratio (FY 28.3%) even as they reiterate it stays "comfortably below 30%," and the prior medium-term quantitative growth framing remains retired with no replacement range.
Headline numbers
EPS
Q4 FY2025
$1.13
Revenue
Q4 FY2025
$3.72B
+1.5% YoY
Key financials
Q4 FY2025| Metric | Q4 FY2025 | YoY | Q3 FY2025 | QoQ |
|---|---|---|---|---|
| Revenue | $3.72B | +1.5% | $3.23B | +15.2% |
| EPS | $1.13 | — | $1.10 | +2.7% |
Guidance
Company issued qualitative FY2026 guidance emphasizing margin stability and capital returns, with effective tax rate (~23%) and expense ratio (comfortably below 30%) disclosed; no prior quarter forward guidance for direct comparison.
Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.
New guidance
| Metric | Period | Guide | YoY |
|---|---|---|---|
| Effective tax rate | FY 2026 | approximately 23% | — |
| Expense ratio | FY 2026 | comfortably below 30% | — |
Segment performance
Q4 FY2025| Segment | Q4 FY2025 | YoY |
|---|---|---|
| Insurance | $2.79B | +5.8% |
| Reinsurance & Monoline Excess | $0.39B | +4.3% |
Capital & returns
Q4 FY2025| Segment | Q4 FY2025 |
|---|---|
| Return on Equity (ROE) | 21.4% |
| Operating Return on Equity | 21.4% |
| Book Value Per Share | $25.72 |
Other KPIs
Q4 FY2025| Segment | Q4 FY2025 |
|---|---|
| Combined Ratio | 89.4% |
| Loss Ratio | 61.2% |
| Expense Ratio | 28.2% |
| Net Premiums Written | $3.0 billion |
| Net Investment Income | $338.2 million |
Management tone
Narrative arc: Q2 growth-runway-reset → Q3 cautious-margin-defense → Q4 confident-investment-cycle-pivot.
Two quarters ago, management was walking down the medium-term growth envelope and framing eroding reinsurance discipline as a constraint. One quarter ago, the quantitative framing was retired entirely in favor of "exceptional value" language, and "we are in business to make good risk-adjusted returns, not solely to issue insurance policies" was the anchor. This quarter, the tone shifted to outright confidence: "the business is really firing on all cylinders. We're generating very strong returns…we're generating capital more quickly, and we can utilize it." This signals the company has moved from defending margin in a softening market to actively redeploying capital and accelerating internal investment — a posture you take when you believe the cycle's worst is being navigated, not feared.
The auto liability arc completed its descent. Q2 was "terrific opportunity, will take a little bit longer." Q3 was "a bit of a puzzle to me." Q4 is resigned: "while we did speak about possibly seeing some green shoots…that proved to be a mirage. The market has continued to find new lows, and our hope is as we make our way towards the end of 26, we find a bottom." This is the first call where management gave a specific timing marker for the cycle bottom, and it's late-2026 — not 2025, not H1 2026. The signal: Berkley will continue to actively shrink this book through 2026, and any peer telling you auto rate is catching up to trend is selling something.
The expense ratio narrative inverted. For multiple quarters, expense management has been framed as a stable strength running below 30%. This quarter, management explicitly told investors to expect "some pretty meaningful investments…on the tech side and the broader banner, both data, AI, et cetera. And that will come as a price." The Q&A confirmed benefits don't materialize until 2027. This is the first multi-year expense-up cycle Berkley has signaled in the visible run of calls, and it lands while the 89.4% combined ratio is at its best — a deliberate choice to invest from a position of strength.
Property reinsurance contagion language sharpened. Q3 was "bloom is off the rose" for property. Q4 is explicit about spillover: "the competitiveness in the property cat market would seem to be spilling over into the casualty market…participants are struggling…with getting to their premium targets on the property front." The implication: the casualty discipline erosion management has flagged for multiple quarters is now being driven not by casualty fundamentals but by property-side desperation. That makes the 1/1 2026 reinsurance pullback structural, not cyclical.
A new theme entered the call: distribution disintermediation. "Traditional partners, traditional distribution oftentimes is not just a partner, but is actually a competitor…Customers are much more comfortable with a self-serve model." This has not appeared in prior briefs and was raised in prepared remarks unprompted — meaning management chose to flag it as a multi-year structural issue, likely linked to the tech investment cycle just announced.
Recurring themes management leaned on this quarter:
Risks management surfaced:
Q&A highlights
Elise Greenspan · Wells Fargo
How will premium growth translate into 2026 given market conditions and reduced pricing pressure? Also, how should investors think about the expense ratio trajectory given AI/tech investments in 2026 described as an 'investment year'?
Insurance primary and excess will likely outperform Q4 2025. Reinsurance market showing signs of challenge. Management expects meaningful AI/tech investments in both 2026 and 2027, with benefits starting to show in 2027 and scaling from there. Expense ratio expected comfortably below 30% in 2026.
Bob Wong · Morgan Stanley
Which lines of business show pricing trends that no longer make sense, potentially requiring exposure reductions in 2026-2027? What are the near-term AI capabilities showing the most promise?
Auto liability is the clear example where pricing does not support continued exposure growth - business is being deliberately shrunk. Professional lines and large account property/shared/layered business also showing concerns due to tight pricing. On AI, current focus is on underwriting intake processes where efficiency gains are dramatic and happening now.
Josh Shanker · Bank of America
Are loss conditions changing beneath the industry's feet, or is the industry simply unable to secure necessary rate increases to match expected loss trends? Are there marginally attractive pockets the company could write but chooses not to?
Company is return-driven, not combined ratio-driven. Different product lines are in different places in the cycle requiring a fine-brush approach. Some lines show green lights (lean in more), some amber, some red. Rather than chase marginal returns, company will decline business where rate doesn't support required return targets.
Brian Meredith · UBS
Does management's comment about laying off rate while keeping margins suggest trend is moderating? Will loss picks remain stable if margins are to be preserved? What is the company's stance on MGA acquisitions given distribution challenges?
Premature to reach confident conclusions on trend moderation, but recent activity suggests company is in comfortable place. Selectively can ease off on pricing pedal. Insurance and reinsurance have different dynamics - insurance can preserve margins more easily. Company will not be aggressively pursuing MGA acquisitions; views delegated authority with caution and believes valuations irrational.
Meyer Shields · KBW
Is the reduced need for rate increases driven by better-than-expected claims frequency/severity emergence on recent accident years? Did this optimism change full-year 2025 loss picks or just reduce pricing pressure?
Early indications across multiple lines suggest recent accident years performing better than expected - includes both claims-made and occurrence lines with tail. Recent underwriting and rate actions having positive impact as hoped. Company did NOT adjust 2025 loss picks; maintains the loss picks but feels less pressure to push rate.
Answers to last quarter's watch list
What to watch into next quarter
Expense ratio direction in Q1 2026. Management told investors to expect "meaningful" tech/AI investment in 2026 with returns in 2027. Watch whether Q1 expense ratio crosses 29.0% — that would mark the first material step-up from the FY 28.3% band and confirm the investment cycle is showing up in the P&L, not deferred.
Net investment income — does the two-quarter sequential decline reverse? With NII at $338.2M (down from $379.3M in Q2), watch whether Q1 2026 prints above $345M. If NII stays in the low-$330s, management's "continued growth" narrative loses credibility and the 21% ROE becomes harder to defend without underwriting upside.
Insurance segment NPW reacceleration. Management explicitly said Insurance primary and excess should grow faster than Q4's pace, and pointed to December and January as evidence. Watch whether Q1 2026 Insurance NPW rebounds above +4% — anything in the +1–2% range would confirm Q4 was the new operating zone, not an aberration.
Reinsurance & Monoline Excess NPW post-1/1. Q4 caught only partial impact of the 1/1 pullback. Watch whether Q1 2026 prints below +2% or turns negative, which would confirm the structural property-into-casualty contagion management flagged this quarter.
Capital return cadence sustainability. With ROE at 21.4% versus a 15% target and Q4's record $608M return setting a high-water mark, watch whether Q1 2026 sustains an elevated repurchase pace or reverts to a more modest cadence. The Q&A explicitly framed buybacks as opportunistic rather than programmatic.
Sources
- W. R. Berkley Corporation Q4 2025 press release (8-K Exhibit 99.1), filed 2026-01-26: https://www.sec.gov/Archives/edgar/data/11544/000001154426000003/wrb123120258-kex991.htm
- Q4 2025 earnings call commentary (Rob Berkley remarks and Q&A, as cited in tone and Q&A extractions).
Get the next brief, free.
We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.
This is not investment advice.